About Glooko
Glooko is a Healthcare company based in Palo Alto (United States) founded in 2010. Diabetes management is enabled via glucose meters and mobile apps. Glooko has raised $201 million across 8 funding rounds from investors including Medtronic, Insulet and Health Catalyst. Glooko has completed 3 acquisitions, including Diasend, Monarch Medical Technologies and xbird. Its chief executive, as recorded, is Mike Alvarez. Its website glooko.com draws about 187 thousand monthly visits. Its focus areas include HealthTech, Healthcare IT, Value Based Care and Remote Monitoring.
Company details
Glooko is a diabetes management solution for patients, health systems, and payer groups. Glookos products enable clinicians to remotely access their patients blood glucose readings and other related data, and optimize their insulin therapy. The companys System allows people with diabetes to download their glucose readings to their mobile devices. According to the company, their population management web app offers diabetes-centric analytics and supplies insightful reports, graphs and pattern-triggered notifications to patients, health systems and payers. Partners include Abbott, Roche, LifeScan, Medtronic, Omnipod, Bayer, Nipro, and Arkray among others. Glooko and Diasend got merged in September 2016 and the combined companies operate under the Glooko moniker.
Apps and channels of Glooko
Glooko publishes 2 mobile apps with over 100K+ downloads; its YouTube channel Glooko has 1.64K subscribers and 30 videos.
Videos from Glooko
The most watched videos on Glooko's YouTube channel, Glooko (1.64K subscribers). Click a video to play it here.
More on Glooko.
Funding Insights of Glooko
Glooko has successfully raised a total of $201M across 8 strategic funding rounds. The most recent funding activity was a Series F round of $100 million completed in October 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $201M
- Total Rounds 8
- Last Round Series F — $100M
- First Round $1M
(Nov 2011)
- Investors Count 23
All 8 funding rounds of Glooko with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Oct 2024 | $100M | Series F | – | Georgian | |
| Mar 2021 | $30M | Series D | – | Health Catalyst Capital | |
| Jun 2017 | $35M | Series C | – | Georgian | |
| Sep 2016 | $8M | Series B | – | Canaan | |
| Mar 2015 | $16.5M | Series B | – | Medtronic, Canaan | |
| Jan 2014 | $7M | Series A | – | Samsung Venture Investment, Social Capital | |
| Jan 2012 | $3.5M | Series A | – | Social Capital | |
| Nov 2011 | $1M | Seed | – | Social Capital |
23 investors in total: 14 institutional and 9 angel.
Investors in Glooko
Glooko has secured backing from 23 investors, including venture fund, institutional, and angel investors. Prominent investors backing the company include Medtronic, Insulet and Health Catalyst.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Venture capital is provided to expanding B2B software companies. | 2008 | georgian.io | Toronto, Canada | |
Canaan is recognized as an early-stage venture capital firm. | 1987 | canaan.com | San Francisco, United States | |
Growth-stage US tech companies are funded by Health Catalyst Capital. | healthcatalystcapital.com | New York, United States | ||
US focused VC firm investing in seed & growth stage companies | 2011 | socialcapital.com | Menlo Park, United States | |
Venture capital fund investing in early-stage tech startups | samsungnext.com | Berlin, Germany | ||
Healthcare startups are accelerated by Mayo Clinic Business Accelerator. | mcbusaccel.com | Rochester, United States | ||
Investments are directed toward semiconductors, telecommunications, software, and medical sectors. | samsungventures.com | Seoul, South Korea | ||
Drugs for diabetes, obesity, hemophilia, and hormone therapy are manufactured. | 1923 | novonordisk.com | Bagsvaerd, Denmark | |
Wearable insulin infusion systems are developed for diabetes patients. | 2000 | insulet.com | Boston, United States | |
General medical clinics are operated throughout the United States. | 1864 | mayoclinic.org | United States |
Investor details for Glooko
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Glooko
90 people are tracked at Glooko (37 in leadership, 6 in board & advisors, 47 in team).
| Name | Role | Group |
|---|---|---|
Mike Alvarez | CEO | Leadership |
Mark Beucler | CFO | Leadership |
Clay Davidson | Vice President, Legal & Privacy | Leadership |
Dan Olson | Senior Vice President, Growth / Commercial ~ North America | Leadership |
Hadley Horton | Senior Partner Manager | Leadership |
Anthony Marino | Director, Fp&a | Leadership |
Prakash Menon | Chief Technology Officer | Leadership |
Alexander Evans | Vice President, Connected Care, EMEA | Leadership |
Seth Gabarro | Vice President, Connected Care Solutions | Leadership |
Mark Scorringe | OUS Partnerships, Vice President | Leadership |
Paul B. | Senior Director Of Sales Operations | Leadership |
Laura Tomaino | Chief People Officer | Leadership |
Daniel Stjern | VP, Product Management & UX | Leadership |
Dan Korelitz | Director Of Data And Machine Learning Products | Leadership |
Ed Marshall | Chief Product Officer | Leadership |
Benjamin C. Chang | Vp, Security And IT Operations | Leadership |
Rich Glenn | President, Connected Care | Leadership |
Kaylin Kelleher | Sr. Director, Customer Success | Leadership |
Antoine Prost | EMEA Marketing Director, Connected Care | Leadership |
Mary Beth McDonald | Vp, Regulatory And Quality Management | Leadership |
70 more people are available in the full profile.
Complete people profiles for Glooko
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Glooko
Glooko has strategically engaged in corporate development activities, having acquired 3 companies. Notable acquisitions include Diasend, Monarch Medical Technologies and xbird.
| Company Name | Description | Domain | Location | Founded | Acquired | Amount |
|---|---|---|---|---|---|---|
Clinical decision support software for inpatient glucose management is provided. | monarchmedtech.com | Charlotte, United States | 2003 | Sep 2025 | •••• | |
Provider of AI-based solutions for diagnosis and health risk assessment | xbird.io | Berlin, Germany | 2015 | Jan 2022 | •••• | |
Web and mobile solution for diabetic patients | diasend.com | Chicago, United States | 2005 | Sep 2016 | •••• |
Complete acquisition details for Glooko
Acquired stakes, deal sources and the complete acquisition history require an active premium plan.
- Acquired stakes
- Deal sources
- Complete history
- Exports
Verified entity values are shown only after access is granted.
Timeline of Glooko
6 dated milestones of Glooko across 15 years, from founding to its latest funding, stage changes and deals.
- Founded Glooko is founded.
- Funding First funding round of $1.0M.
- Acquisition Acquires Diasend.
- Acquisition Acquires xbird.
- Funding Latest funding round, Series F, of $100.0M.
- Acquisition Acquires Monarch Medical Technologies.
Web traffic of Glooko
The website of Glooko (glooko.com) receives about 187K visits a month and ranks #205,718 among all websites worldwide, #6,674 in Health Conditions and Concerns.
- Monthly visits187K
▲ 18.1% vs previous month
- Unique visitors66.1K
per month
- Global rank#205,718
among all websites
- Category rank#6,674
Health · Health Conditions and Concerns
- Bounce rate39%
- Pages per visit4.5
- Average visit2 min 54 sec
- DevicesDesktop 40% · Mobile 60%
Websites whose visitors overlap most with Glooko. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| glucosebuddy.com | 100% | #4,893,720 | View details | ||
| diabetesmine.com | 89% | View details | |||
| diabetes.org | 83% | 1.4M | #43,191 | View details | |
www2.jdrf.org | www2.jdrf.org | 82% | – | ||
| idf.org | 82% | 238.3K | #206,973 | View details | |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 27 similar websites and full traffic analytics for Glooko
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 27 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Top companies in Clinical IT & Data Platforms
3 companies that operate in the same segment as Glooko (Clinical IT & Data Platforms) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Employee health benefits are facilitated via a cloud-based platform. | 2007 | Plymouth Meeting, Pennsylvania, United States | USD 228.3 M | |||
Healthcare appointments are booked online via Zocdoc's platform. | 2007 | New York, New York, United States | USD 425.97 M | USD 4.66 M | 1,365 | |
Virtual physical therapy and digital pain care solutions are provided. | 2015 | San Francisco, California, United States | USD 854.44 M | 1,746 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Glooko
Complete news archive for Glooko
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Glooko
Glooko was founded in 2010 and raised its 1st funding round 1 year after it was founded.
Glooko is headquartered in Palo Alto, United States. It is registered at Palo Alto, California, United States.
Mike Alvarez is the CEO of Glooko, as recorded in our data.
Glooko is a funded company, having raised a total of $201M across 8 funding rounds to date. The company's 1st funding round was a Seed of $1M, raised on Nov 2011.
Glooko is a diabetes management solution for patients, health systems, and payer groups. Glookos products enable clinicians to remotely access their patients blood glucose readings and other related data, and optimize their insulin therapy. The companys System allows people with diabetes to download their glucose readings to their mobile devices. According to the company, their population management web app offers diabetes-centric analytics and supplies insightful reports, graphs and pattern-triggered notifications to patients, health systems and payers. Partners include Abbott, Roche, LifeScan, Medtronic, Omnipod, Bayer, Nipro, and Arkray among others. Glooko and Diasend got merged in September 2016 and the combined companies operate under the Glooko moniker.
Glooko has made 3 acquisitions, including Diasend, Monarch Medical Technologies, and xbird.
Glooko has 23 investors. Key investors include Medtronic, Insulet, Health Catalyst, Novo Nordisk, and Mayo Clinic.
Yes. Glooko publishes Glooko - Track Diabetes Data and 1 more app, with over 100,000 downloads.
The website of Glooko receives about 187 thousand visits a month and ranks #205,718 among all websites worldwide.